A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...

The fear over the spread of HMPV virus that led to concerns if it will trigger Covid-19-like health emergency. Is HMPV same ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.

While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...

COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after you’ve ...

Despite studying the SARS-CoV-2 virus for five years, scientists still have questions, from the extent to which it can ...

COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised ...

New data from the U.S. Centers for Disease Control and Prevention ( CDC) shows that over half of U.S. states have either "high" or "very high" levels of SARS-CoV-2—the virus that causes COVID-19—in ...

Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...